Miller on Oncology

 
 
  • Do You Want a Cola or a Cure?   Dr. Miller reports that US funds for cancer research amount to 69 cents per person per week. Put another way, cancer research dollars amount to one sixth of what Americans spend on soft drinks.
  • Is Mandatory Biopsy in Clinical Trials Justifiable?   Dr. Kathy Miller weighs the ethical concerns about requiring biopsies to participate in breast cancer clinical trials against the critical gains in therapeutic efficacy those biopsies permit.
  • Where to Find Secret Pearls at ASCO® 2010   Dr. Kathy Miller highlights the patient and survivor care sessions at ASCO that abound in science and practical methods for improving the lives of cancer patients.
  • A Commitment to the Cure Well Outside the Normal Range   Dr. Kathy Miller lauds her colleagues who spearheaded the tissue bank at the IU Simon Cancer Center and the 1000 women who donated normal breast tissue to support breast cancer research.
  • Predicting Brain Metastases: Is It a Good Thing?   The development of a tool that accurately predicts brain metastases in patients with metastatic breast cancer prompts Dr. Kathy Miller to consider the potential benefit and harm of such information.
  • CYP2D6 Testing: Not Ready for Prime Time   Studies have examined whether CYP2D6 testing can identify breast cancer patients who ought (or ought not) to be treated with tamoxifen, but Dr. Kathy Miller says the jury is still out on this assay.
  • The Decline in Scientific Literacy and Its Impact on Medicine   The public decline in scientific literacy, according to Dr. Kathy Miller, may be the most important problem facing medicine.
  • Exercise May Put Breast Cancer on the Run   Dr. Kathy Miller discusses a study that found that sedentary postmenopausal women who exercise regularly experience changes in estradiol and SHBG levels consistent with a lower risk for breast cancer.
  • Can Aspirin Prevent Breast Cancer Recurrence?   Dr. Kathy Miller reviews findings from the Nurses Health Study suggesting that regular aspirin consumption is associated with a decreased risk for distant recurrence and breast cancer death.
  • Breast Cancer Testing: A Matter of Medicine or Marketing?   Direct-to-consumer marketing for BRCA analysis leads women to question whether to be tested, prompting Dr. Kathy Miller to advise physicians to talk to their patients about breast cancer risk.
  • DCIS and the Power of Words   The word carcinoma impacts how patients and physicians think about ductal carcinoma in situ. Dr. Kathy Miller considers whether a change in name could influence a change in practice.
  • Can Acupuncture Control Hot Flashes in Breast Cancer Patients?   Vasomotor symptoms are common side effects of antiestrogen hormone treatment in breast cancer care. In this video blog, Dr. Kathy Miller discusses acupuncture as a promising therapy for hot flashes.
  • Lymph Nodes May Provide Clues for Targeted Breast Cancer Treatment   In this video blog, Dr. Kathy Miller talks about differences in receptor expression between primary and nodal disease that may help identify subsets of breast cancer cells most likely to metastasize.
  • How Low Would You Go?   In this video blog, Dr. Kathy Miller discusses factors affecting the use of systemic adjuvant therapy for HER2 breast cancer patients who have small tumors.
  • Mining the Data of Clinical Trials   Re-examining clinical data proves a goldmine of new information for other areas of cancer study, as examined by Dr. Kathy Miller in this video blog from SABCS.
  • The Real Issue in the Debate Over the USPSTF Guidelines   In this video blog, Dr. Kathy Miller identifies the real issue in breast cancer screening: One third of American women who would benefit do not get screened because of lack of access.
  • Breast Cancer Screening: How Important Is Breast Self-Examination?   In this video blog, Dr. Kathy Miller discusses a large Chinese study that found that breast self-examination did not improve disease stage at diagnosis or overall survival.
  • Joint Pain Associated With Aromatase Inhibitors in Patients With Breast Cancer   In her latest video blog, Dr. Kathy Miller comments on a new study examining the incidence of arthralgia associated with aromatase inhibitor therapy in patients with breast cancer.
  • Can Doctors Ever Tell Patients They Are Cured of Cancer?   In her first Medscape video blog, Dr. Kathy Miller asks whether doctors should avoid using the term cured to describe patients who have been in remission for several years.